13FBRIDGEBIO PHARMA INC (BBIO)
7 tracked managers currently hold BBIO on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | Q2 2026 | TRIM | $741.0M | 2.1 % | 2.5 % | 9,949,219 | -1,893,215 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $351.7M | 0.3 % | 0.2 % | 4,722,185 | +1,601,554 |
| CITADEL ADVISORS LLC | Q2 2026 | ADD | $280.0M | 0.2 % | 0.2 % | 3,760,028 | +586,088 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $270.6M | 0.2 % | 0.1 % | 3,633,007 | +1,087,521 |
| Point72 Asset Management, L.P. | Q2 2026 | NEW | $113.6M | 0.2 % | — | 1,525,782 | NEW |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | TRIM | $36.3M | 0.0 % | 0.0 % | 487,594 | -145,689 |
| Bridgewater Associates, LP | Q2 2026 | ADD | $33.4M | 0.1 % | 0.1 % | 448,143 | +188,684 |